Related Experiment Video
Updated: Mar 14, 2026
07:36
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
2.0K
Boswellic Acids and Their Role in Chronic Inflammatory Diseases
H P T Ammon1,2
1Department of Pharmacology and Toxicology, Institute of Pharmaceutical Sciences, University of Tuebingen, Auf der Morgenstelle 8, 72076, Tuebingen, Germany. info@hptammon.de.
Advances in Experimental Medicine and Biology
|September 28, 2016
Summary
Boswellic acids from Boswellia species show anti-inflammatory effects by inhibiting cytokines and proteases. Clinical studies indicate symptom improvement in 60-70% of patients with chronic inflammatory diseases, with minimal side effects.
Area of Science:
- Pharmacology and Natural Products Chemistry
- Immunology and Inflammation Research
Background:
- Boswellic acids (BAs), pentacyclic triterpenes from Boswellia species resin, possess significant pharmacological activity.
- While over 12 BAs exist, KBA and AKBA are of primary pharmacological interest due to their anti-inflammatory mechanisms.
Purpose of the Study:
- To investigate the biological activity and therapeutic potential of Boswellia extracts (BEs) and specific boswellic acids (BAs).
- To explore the anti-inflammatory mechanisms, pharmacokinetics, clinical efficacy, and safety of BAs in chronic inflammatory conditions.
Main Methods:
- Analysis of anti-inflammatory actions including inhibition of leukotriene and prostaglandin synthesis, complement system modulation, and cytokine production (IL-1, IL-2, IL-6, IFN-γ, TNF-α).
- Investigation of specific targets like NF-κB for AKBA and suppression of proteolytic enzymes (cathepsin G, human leucocyte elastase).
- Pharmacokinetic assessment of KBA and AKBA absorption, including the effect of high-fat meals, and review of clinical studies on various inflammatory diseases.
Main Results:
- BAs inhibit key inflammatory mediators and decrease pro-inflammatory cytokine production, targeting immune system pathways.
- AKBA is a potent inhibitor of NF-κB, while both BAs and BEs suppress tissue-degrading enzymes.
- KBA shows better absorption than AKBA, but both are significantly enhanced by high-fat meals; clinical studies show 60-70% symptom improvement in rheumatoid arthritis, osteoarthritis, colitis, and asthma with low incidence of gastrointestinal side effects.
Conclusions:
- Boswellia extracts and their active compounds, particularly KBA and AKBA, demonstrate broad anti-inflammatory effects through multiple mechanisms.
- Clinical evidence supports the efficacy of Boswellia resin treatment for chronic inflammatory diseases, offering symptom improvement with a favorable safety profile.
- Further research into optimizing BA absorption and therapeutic application is warranted for managing inflammatory conditions.
Related Concept Videos
01:28Inflammatory Response
18.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
18.0K
01:17Chronic Bowel Disorders: Introduction
873
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
873
01:38Inflammation
63.6K
Overview
63.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
591
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
591
01:29Inflammatory Bowel Disease IV: Pharmacological Management
893
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
893